Jump to:
loading...| Preferred Name |
Deferiprone |
|
| Synonyms |
|
|
| Definitions |
An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C73030 |
|
| Accepted_Therapeutic_Use_For |
Hemosiderosis |
|
| CAS_Registry |
30652-11-0 |
|
| Chemical_Formula |
C7H9NO2 |
|
| code |
C73030 |
|
| Contributing_Source |
FDA |
|
| definition |
An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body. |
|
| FDA_UNII_Code |
2BTY8KH53L |
|
| in_subset | ||
| label |
Deferiprone |
|
| Legacy Concept Name |
Deferiprone |
|
| NCI_Drug_Dictionary_ID |
761978 |
|
| PDQ_Closed_Trial_Search_ID |
761978 |
|
| PDQ_Open_Trial_Search_ID |
761978 |
|
| Preferred_Name |
Deferiprone |
|
| prefixIRI |
NCIT:C73030 |
|
| prefLabel |
Deferiprone |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0043832 |
|
| subClassOf |
Create mapping